Room-Tariff Caps Won't Fix India's Hospital Bills - Only DRG Payment Will

Why Capping One Line on the Bill Won't Lower the Bill

India's hospitals hand patients bills built from dozens of separately priced components - room charges, tests, procedures, medicines, consumables. The Parliamentary Standing Committee's proposal to cap the room-tariff component, benchmarking it to a nearby three-star hotel, treats one line on that bill as if it were the whole problem.

It isn't and treating it as one will produce a familiar and predictable failure: hospitals will simply raise the components that remain uncapped. This is not speculation about hospital behaviour; it is how price regulation works whenever it targets a single component of a multi-part transaction.

Cap the room charge and a hospital facing the same cost structure and the same revenue expectations does not absorb the loss - it redistributes it into diagnostics, "package" procedures or medicine mark-ups that are harder for a patient or regulator to scrutinise line by line.

The room tariff is visible and easy to compare to a hotel; a bundle of billed procedures is not. The alternative that actually addresses the underlying problem is a Diagnosis-Related-Group payment system - a fixed, predetermined reimbursement for an inpatient stay based on diagnosis and procedures, rather than itemised billing for each service rendered.

Under DRG, a hospital cannot recover a capped room charge by adding an unnecessary scan, because the total payment for that diagnosis is fixed regardless of how many additional services are billed. This directly targets what the Committee's own report identifies as the deeper issue: healthcare's information asymmetry, where patients rarely have the independent expertise to judge whether an MRI, an extra hospital day or a procedure was actually necessary - leaving that judgment and the financial incentive attached to it, in the hands of the provider.

The strongest objection to this position is a real one, not a strawman: aggressive price regulation, including DRG systems poorly calibrated at the outset, risks deterring the private and foreign capital India genuinely needs to expand hospital capacity in underserved Tier-2 and Tier-3 cities.

Capital requires predictable returns and if regulation is unpredictable or punitive, investment can simply go elsewhere, slowing the very capacity expansion India needs. That risk is real, but it argues for how DRG should be designed and phased, not against DRG itself.

A well-calibrated DRG system, unlike an isolated tariff cap, gives investors a predictable, rules-based reimbursement structure they can actually plan around - arguably more investment-friendly than a patchwork of ad hoc caps imposed piecemeal on whichever line item draws public attention next.

The choice is not between regulation and no regulation; isolated caps are already a form of regulation, just a poorly designed one. What genuinely deters investment is not comprehensive, predictable regulation - it is unpredictable, incomplete regulation that leaves hospitals guessing which component gets capped next.

India needs a DRG framework introduced with adequate transition time and reasonable base rates, not a room-tariff cap that solves nothing while creating the appearance of action.